To implement the requirements set forth in the State Council's Notice on the Issuance of Work Plan for Optimizing the Business Environment at Ports to Promote Cross-Border Trade Facilitation (State Council [2018] Notice No. 37) and the State Council's requirements for online application and online processing of all import and export supervision documents before the end of 2019, NMPA and the General Administration of Customs jointly established a drug import and export permit management system on the One-stop Window Public Platform for International Trade. On December 27, 2019, NMPA issued the Notice on Enabling the Import and Export Permit Management System, which clearly states that the drug import and export permit management system has been officially launched since December 25, 2019, and shall be used to handle online the whole-process application, acceptance, approval and network verification of import and export of anabolic agents and peptide hormones.